Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
New
Increased
Maintained
Reduced
Closed
Funds Holding
3,876
Funds Holding Change
0
Funds Holding Growth
0%
Value
$1.29T
Holding in Top 10
1,173
Top 10 Change
-76
Top 10 Growth
-6%
Value Growth
+3%
New
120
Increased
1,917
Reduced
1,623
Closed
79
Capital Inflow
$38B
Capital Outflow
$36.7B
Net Capital Flow
+$1.26B
Capital Flow Change
-$32.9B
Calls
$15B
Puts
$15.2B
Net Calls
-$194M
Put/Call Ratio
1.01